Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
1,474
+2
+0.1% +$1.69K 0.16% 70
2026
Q1
$1.09M Sell
1,472
-38
-3% -$27.7K 0.17% 69
2025
Q4
$924K Sell
1,510
-36
-2% -$23.3K 0.13% 77
2025
Q3
$1M Sell
1,546
-5
-0.3% -$3.03K 0.15% 74
2025
Q2
$830K Sell
1,551
-55
-3% -$24.3K 0.13% 82
2025
Q1
$594K Sell
1,606
-62
-4% -$26.8K 0.1% 107
2024
Q4
$757K Sell
1,668
-6
-0.4% -$2.84K 0.13% 88
2024
Q3
$721K Buy
1,674
+48
+3% +$18.1K 0.13% 94
2024
Q2
$594K Buy
+1,626
New +$600K 0.11% 102

Other funds holding EME

CFO4Life Group's EME Position: Q2 2026 in Review

CFO4Life Group increased its Emcor (EME) stake by 0.14% in Q2 2026, buying an estimated $1.69K and bringing the position to 1,474 shares worth $1.22M. The position accounts for 0.16% of the portfolio, ranked #70.

CFO4Life Group first reported a position in EME in Q2 2024 and has held it in 9 quarters since. 1,246 funds tracked by Wall St. Rank hold EME as of Q2 2026.

  • CFO4Life Group held 1,474 shares of Emcor worth $1.22M as of Q2 2026.
  • CFO4Life Group bought 2 Emcor shares in Q2 2026, an estimated $1.69K.
  • Emcor made up 0.16% of CFO4Life Group's portfolio in Q2 2026, its #70 holding.
  • CFO4Life Group first reported a position in Emcor in Q2 2024 and has held it in 9 quarters since.
  • 1,246 funds tracked by Wall St. Rank held Emcor as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.